Sponsored by: EY | Unlocking Value Through AI at Takeda Pharmaceuticals

In the rapidly evolving landscape of pharmaceuticals, the integration of AI and GenAI is transforming how organizations operate and deliver value. We will explore the profound impact of the AI program at Takeda Pharmaceuticals and the central role of Databricks. We will delve into eight pivotal AI/GenAI use cases that enhance operational efficiency across commercial, R&D, manufacturing, and back-office functions, including these capabilities:

• Responsible AI Guardrails: Scanners that validate and enforce responsible AI controls on GenAI solutions
• Reusable Databricks Native Vectorization Pipeline: A scalable solution enhancing data processing with quality and governance
• One-Click Deployable RAG Pattern: Simplifying deployment for AI applications, enabling rapid experimentation and innovation
• AI Asset Registry: A repository for foundational models, vector stores, and APIs, promoting reuse and collaboration